drug
(carbidopa + levodopa)
Marketedupdated 3mo agoby Avion Pharmaceuticals LLC
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 8- tagApproval8 co-mentions · 4 sources
- drugSINEMET CR5 co-mentions · 5 sources
- tagSmall Molecule4 co-mentions · 4 sources
- companyEmory University1 co-mentions · 1 sources
- tagMajor Depression1 co-mentions · 1 sources
- druglevodopa1 co-mentions · 1 sources
- drug(carbidopa + levodopa) CR1 co-mentions · 1 sources
- druglevodopa CR1 co-mentions · 1 sources
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 4 approved and 24 investigational indications.
indications
investigational
Parkinson's Disease
all catalysts(1)
Patent cliff
source: FDA Orange Bookfirst barrier falls
Aug 7, 2027
351 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (151)
- Dec 21, 2041method-of-use (U-219)US 11986449
- Dec 21, 2041method-of-use (U-219)US 11986449
- Dec 21, 2041method-of-use (U-219)US 11986449
- Dec 21, 2041method-of-use (U-219)US 11986449
- Dec 21, 2041method-of-use (U-4005)US 12109185
- Dec 21, 2041method-of-use (U-4005)US 12109185
- Dec 21, 2041method-of-use (U-4005)US 12109185
- Dec 21, 2041method-of-use (U-4005)US 12109185
- Dec 21, 2041method-of-use (U-219)US 12194150
- Dec 21, 2041method-of-use (U-219)US 12194150
- Dec 21, 2041method-of-use (U-219)US 12194150
- Dec 21, 2041method-of-use (U-219)US 12194150
- Dec 21, 2041method-of-use (U-4005)US 12201596
- Dec 21, 2041method-of-use (U-4005)US 12201596
- Dec 21, 2041method-of-use (U-4005)US 12201596
- Dec 21, 2041method-of-use (U-4005)US 12201596
- Dec 21, 2041method-of-use (U-4005)US 12263148
- Dec 21, 2041method-of-use (U-4005)US 12263148
- Dec 21, 2041method-of-use (U-4005)US 12263148
- Dec 21, 2041method-of-use (U-4005)US 12263148
- Dec 21, 2041method-of-use (U-4005)US 12263149
- Dec 21, 2041method-of-use (U-4005)US 12263149
- Dec 21, 2041method-of-use (U-4005)US 12263149
- Dec 21, 2041method-of-use (U-4005)US 12263149
- Dec 21, 2041method-of-use (U-219)US 12295931
- Dec 21, 2041method-of-use (U-1649)US 12295931
- Dec 21, 2041method-of-use (U-1649)US 12295931
- Dec 21, 2041method-of-use (U-1649)US 12295931
- Dec 21, 2041method-of-use (U-4005)US 12303481
- Dec 21, 2041method-of-use (U-4005)US 12303481
- Dec 21, 2041method-of-use (U-4005)US 12303481
- Dec 21, 2041method-of-use (U-4005)US 12303481
- Dec 21, 2041method-of-use (U-219)US 12303482
- Dec 21, 2041method-of-use (U-1649)US 12303482
- Dec 21, 2041method-of-use (U-1649)US 12303482
- Dec 21, 2041method-of-use (U-1649)US 12303482
- Dec 21, 2041method-of-use (U-4005)US 12370163
- Dec 21, 2041method-of-use (U-4005)US 12370163
- Dec 21, 2041method-of-use (U-4005)US 12370163
- Dec 21, 2041method-of-use (U-4005)US 12370163
- Dec 21, 2041method-of-use (U-4005)US 12447139
- Dec 21, 2041method-of-use (U-4005)US 12447139
- Dec 21, 2041method-of-use (U-4005)US 12447139
- Dec 21, 2041method-of-use (U-4005)US 12447139
- Dec 21, 2041method-of-use (U-1649)US 12453710
- Dec 21, 2041method-of-use (U-1649)US 12453710
- Dec 21, 2041method-of-use (U-1649)US 12453710
- Dec 21, 2041method-of-use (U-1649)US 12453710
- Dec 21, 2041method-of-use (U-1649)US 12458616
- Dec 21, 2041method-of-use (U-219)US 12458616
- Dec 21, 2041method-of-use (U-1649)US 12458616
- Dec 21, 2041method-of-use (U-1649)US 12458616
- Mar 28, 2039formulationUS 11033521
- Mar 28, 2039method-of-use (U-3557)US 11439613
- Mar 28, 2039method-of-use (U-3557)US 11819485
- Oct 7, 2034formulationUS 10098845
- Oct 7, 2034formulationUS 10098845
- Oct 7, 2034formulationUS 10098845
- Oct 7, 2034formulationUS 10098845
- Oct 7, 2034formulationUS 10292935
- Oct 7, 2034formulationUS 10292935
- Oct 7, 2034formulationUS 10292935
- Oct 7, 2034formulationUS 10292935
- Oct 7, 2034formulationUS 10688058
- Oct 7, 2034formulationUS 10688058
- Oct 7, 2034formulationUS 10688058
- Oct 7, 2034formulationUS 10688058
- Oct 7, 2034formulationUS 10973769
- Oct 7, 2034formulationUS 10973769
- Oct 7, 2034formulationUS 10973769
- Oct 7, 2034formulationUS 10973769
- Oct 7, 2034formulationUS 10987313
- Oct 7, 2034formulationUS 10987313
- Oct 7, 2034formulationUS 10987313
- Oct 7, 2034formulationUS 10987313
- Oct 7, 2034formulationUS 11357733
- Oct 7, 2034formulationUS 11357733
- Oct 7, 2034formulationUS 11357733
- Oct 7, 2034formulationUS 11357733
- Oct 7, 2034formulationUS 11622941
- Oct 7, 2034formulationUS 11622941
- Oct 7, 2034formulationUS 11622941
- Oct 7, 2034formulationUS 11622941
- Oct 7, 2034formulationUS 11666538
- Oct 7, 2034formulationUS 11666538
- Oct 7, 2034formulationUS 11666538
- Oct 7, 2034formulationUS 11666538
- Oct 7, 2034formulationUS 12064521
- Oct 7, 2034formulationUS 12064521
- Oct 7, 2034formulationUS 12064521
- Oct 7, 2034formulationUS 12064521
- Oct 7, 2034formulationUS 12128141
- Oct 7, 2034formulationUS 12128141
- Oct 7, 2034formulationUS 12128141
- Oct 7, 2034formulationUS 12128141
- Oct 7, 2034formulationUS 12178918
- Oct 7, 2034formulationUS 12178918
- Oct 7, 2034formulationUS 12178918
- Oct 7, 2034formulationUS 12178918
- Oct 7, 2034formulationUS 12178919
- Oct 7, 2034formulationUS 12178919
- Oct 7, 2034formulationUS 12178919
- Oct 7, 2034formulationUS 12178919
- Oct 7, 2034formulationUS 12274793
- Oct 7, 2034formulationUS 12274793
- Oct 7, 2034formulationUS 12274793
- Oct 7, 2034formulationUS 12274793
- Oct 7, 2034formulationUS 12303605
- Oct 7, 2034formulationUS 12303605
- Oct 7, 2034formulationUS 12303605
- Oct 7, 2034formulationUS 12303605
- Oct 7, 2034formulationUS 12403099
- Oct 7, 2034formulationUS 12403099
- Oct 7, 2034formulationUS 12403099
- Oct 7, 2034formulationUS 12403099
- Oct 7, 2034formulationUS 12491164
- Oct 7, 2034formulationUS 12491164
- Oct 7, 2034formulationUS 12491164
- Oct 7, 2034formulationUS 12491164
- Dec 26, 2028formulationUS 83774742.4y
- Dec 26, 2028formulationUS 83774742.4y
- Dec 26, 2028formulationUS 83774742.4y
- Dec 26, 2028formulationUS 83774742.4y
- Dec 26, 2028formulationUS 84549982.4y
- Dec 26, 2028formulationUS 84549982.4y
- Dec 26, 2028formulationUS 84549982.4y
- Dec 26, 2028formulationUS 84549982.4y
- Dec 26, 2028formulationUS 85572832.4y
- Dec 26, 2028formulationUS 85572832.4y
- Dec 26, 2028formulationUS 85572832.4y
- Dec 26, 2028formulationUS 85572832.4y
- Dec 26, 2028formulationUS 90896072.4y
- Dec 26, 2028formulationUS 90896072.4y
- Dec 26, 2028formulationUS 90896072.4y
- Dec 26, 2028formulationUS 90896072.4y
- Dec 26, 2028formulationUS 90896082.4y
- Dec 26, 2028formulationUS 90896082.4y
- Dec 26, 2028formulationUS 90896082.4y
- Dec 26, 2028formulationUS 90896082.4y
- Dec 26, 2028formulationUS 94632462.4y
- Dec 26, 2028formulationUS 94632462.4y
- Dec 26, 2028formulationUS 94632462.4y
- Dec 26, 2028formulationUS 94632462.4y
- Dec 26, 2028formulationUS 95330462.4y
- Dec 26, 2028formulationUS 95330462.4y
- Dec 26, 2028formulationUS 95330462.4y
- Dec 26, 2028formulationUS 95330462.4y
- Dec 26, 2028formulationUS 99016402.4y
- Dec 26, 2028formulationUS 99016402.4y
- Dec 26, 2028formulationUS 99016402.4y
- Dec 26, 2028formulationUS 99016402.4y
FDA exclusivities (4)
- Aug 7, 2027NPNP351d
- Aug 7, 2027NPNP351d
- Aug 7, 2027NPNP351d
- Aug 7, 2027NPNP351d
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 38m ago
Found something off?
comments(0)
5-min edit window · permanent after that